drugset / Trial / NCT01075529

Early Prediction of Fluoxetine Response

NCT01075529

Phase 4 Completed 140 enrolled Kaohsiung Kai-Suan Psychiatric Hospital
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to identify what degree of symptom changes during the early weeks could be used to predict eventual nonresponse at week 6 among depressive inpatients taking fluoxetine.

Timeline

Start
2007-03
Primary completion
2010-02
Completion
2010-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluoxetine Small molecule 20 mg